Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H12O2 |
| Molecular Weight | 212.2439 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OCC1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=SESFRYSPDFLNCH-UHFFFAOYSA-N
InChI=1S/C14H12O2/c15-14(13-9-5-2-6-10-13)16-11-12-7-3-1-4-8-12/h1-10H,11H2
| Molecular Formula | C14H12O2 |
| Molecular Weight | 212.2439 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://en.wikipedia.org/wiki/Benzyl_benzoate
http://www.drugbank.ca/drugs/DB00676
Curator's Comment: description was created based on several sources, including:
https://en.wikipedia.org/wiki/Benzyl_benzoate
http://www.drugbank.ca/drugs/DB00676
Benzyl benzoate is an organic compound with the formula C6H5CH2O2CC6H5. It is the ester of benzyl alcohol and benzoic acid. It forms either a viscous liquid or solid flakes and has a weak, sweet-balsamic odor. It occurs in a number of blossoms (e. g. tuberose, hyacinth) and is a component of Balsam of Peru and Tolu balsam. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. Benzyl benzoate is one of the older preparations used to treat scabies. Scabies is a skin infection caused by the mite sarcoptes scabiei. It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. Benzyl benzoate is lethal to this mite and so is useful in the treatment of scabies. It is also used to treat lice infestation of the head and body. Benzyl benzoate is not the treatment of choice for scabies due to its irritant properties. Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, benzyl benzoate has been found to kill the Sarcoptes mite within 5 minutes.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Inactive ingredient | BRIGHTENING DYNAMICS TRAVELING KIT JAFRA Approved UseHelps prevent sunnburn. If used as directed, with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. |
|||
| Curative | BENZYL BENZOATE Approved UseUnknown Launch Date1976 |
|||
| Curative | BENZYL BENZOATE Approved UseUnknown Launch Date1976 |
Doses
| Dose | Population | Adverse events |
|---|---|---|
10 % 1 times / day multiple, topical Dose: 10 %, 1 times / day Route: topical Route: multiple Dose: 10 %, 1 times / day Sources: |
unhealthy, 4.7 years (range: 6 months - 15 years) Health Status: unhealthy Age Group: 4.7 years (range: 6 months - 15 years) Sources: |
Other AEs: Localised skin reaction... |
25 % 1 times / day multiple, topical Dose: 25 %, 1 times / day Route: topical Route: multiple Dose: 25 %, 1 times / day Sources: |
pregnant, adult |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Localised skin reaction | 12 patients | 10 % 1 times / day multiple, topical Dose: 10 %, 1 times / day Route: topical Route: multiple Dose: 10 %, 1 times / day Sources: |
unhealthy, 4.7 years (range: 6 months - 15 years) Health Status: unhealthy Age Group: 4.7 years (range: 6 months - 15 years) Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Acaricidal activities of paeonol and benzoic acid from Paeonia suffruticosa root bark and monoterpenoids against Tyrophagus putrescentiae (Acari: Acaridae). | 2006-06 |
|
| Aluminum sulfate significantly reduces the skin test response to common allergens in sensitized patients. | 2006-02-14 |
|
| Crusted scabies in an adult T-cell leukemia/lymphoma patient successfully treated with oral ivermectin. | 2006-02 |
|
| Chemical-physical characterization and in vitro preliminary biological assessment of hyaluronic acid benzyl ester-hydroxyapatite composite. | 2006-01 |
|
| Deazapurine solid-phase synthesis: combinatorial synthesis of a library of N3,N5,C6-trisubstituted pyrrolo[3,2-d]pyrimidine derivatives on cross-linked polystyrene bearing a cysteamine linker. | 2005-11-15 |
|
| In vitro release of insulin and biocompatibility of in situ forming gel systems. | 2005-11-04 |
|
| Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants. | 2005-10-29 |
|
| Structure-activity studies of 3'-4'-dichloro-meperidine analogues at dopamine and serotonin transporters. | 2005-10-01 |
|
| Design of wide-spectrum inhibitors targeting coronavirus main proteases. | 2005-10 |
|
| Free radical generation during chemical depolymerization of heparin. | 2005-09-15 |
|
| Pthiriasis capitis. | 2005-09 |
|
| Oligonucleotides conjugated to short lysine chains. | 2005-07-21 |
|
| Food protective effect of acaricidal components isolated from anise seeds against the stored food mite, Tyrophagus putrescentiae (Schrank). | 2005-06 |
|
| Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation. | 2005-05-13 |
|
| Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin. | 2005-05-02 |
|
| Acaricidal activity of active constituent isolated in Chamaecyparis obtusa leaves against Dermatophagoides spp. | 2005-03-23 |
|
| SAR studies of brasilicardin A for immunosuppressive and cytotoxic activities. | 2005-03-01 |
|
| Floral scent emission and pollinator attraction in two species of Gymnadenia (Orchidaceae). | 2005-02 |
|
| Structure formation in injectable poly(lactide-co-glycolide) depots. II. Nature of the gel. | 2005-01-15 |
|
| Immunobiological [correction of Immunobioloical] activity of a new benzyl benzoate from the aerial parts of Solidago virga-aurea var. gigantea. | 2005-01 |
|
| Efficacy of various synthetic pyrethroid-impregnated encasement materials against house dust mite under laboratory conditions. | 2005 |
|
| In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems. | 2005 |
|
| Acaricidal activity of Paeonia suffruticosa root bark-derived compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae). | 2004-12-29 |
|
| Design, synthesis, and photochemical behavior of poly(benzyl ester) dendrimers with azobenzene groups throughout their architecture. | 2004-12-24 |
|
| In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. | 2004-12-15 |
|
| Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. | 2004-11 |
|
| The transmediastinal arteries of the human testis: an anatomical study. | 2004-10 |
|
| Drug release from injectable depots: two different in vitro mechanisms. | 2004-09-30 |
|
| Cytocompatibility and viscoelastic properties of phthalate ester-free tissue conditioners. | 2004-09 |
|
| 3 dimensional modelling of early human brain development using optical projection tomography. | 2004-08-06 |
|
| [Nosocomial infection of scabies in national hospitals and sanatoria in Japan]. | 2004-07 |
|
| Phytochemistry and preliminary biological evaluation of Cyathostemma argenteum, a malaysian plant used traditionally for the treatment of breast cancer. | 2004-07 |
|
| Rapid and sensitive quantitative analysis of alkyl phosphates in urine after organophosphate poisoning. | 2004-06-11 |
|
| Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae). | 2004-05-19 |
|
| Genetic and molecular basis of grass cell-wall degradability. I. Lignin-cell wall matrix interactions. | 2004-05 |
|
| An evaluation of Hyalofill-F plus compression bandaging in the treatment of chronic venous ulcers. | 2004-05 |
|
| Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. | 2004-05 |
|
| Synthesis of [323]-p-octiphenyls: orthogonal functionalization along a rigid-rod scaffold for refined supramolecular architecture. | 2004-03-18 |
|
| Controlled release of a model protein lysozyme from phase sensitive smart polymer systems. | 2004-03-01 |
|
| Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: assessment of weight gain, liver function, nutrient digestibility, wool production and meat quality. | 2004-03 |
|
| Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: epidemiology; assessment of clinical, haematological, cell-mediated humoral immune responses and pathology. | 2004-03 |
|
| p-Anisaldehyde: acaricidal component of Pimpinella anisum seed oil against the house dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus. | 2004-03 |
|
| Inhibition of alpha-chymotrypsin with thiol-bearing substrate analogues in the presence of zinc ion. | 2004-02-09 |
|
| The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs. | 2004-02 |
|
| Leaching of plasticizers from temporary denture soft lining materials. | 2004-02 |
|
| [Reconstruction of extensive soft tissue loss by transplantation of dermal and epidermal equivalents]. | 2004-01 |
|
| The efficacy of benzyl benzoate sprays in killing the storage mite Tyrophagus putrescentiae (Acari: Acaridae). | 2004 |
|
| Controlling scabies in institutional settings: a review of medications, treatment models, and implementation. | 2004 |
|
| Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design. | 2003-12-31 |
|
| Gland cell cultures into 3D hyaluronan-based scaffolds. | 2003-08 |
Patents
Sample Use Guides
30 mL of the lotion usually is sufficient for one application in adults and 20 mL usually is sufficient in children. The patient should bathe 24–48 hours after the last application to remove the drug.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10748911
no mites were alive after 3 h exposure to 25% benzyl benzoate (Ascabiol)
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:46 GMT 2025
by
admin
on
Mon Mar 31 17:50:46 GMT 2025
|
| Record UNII |
N863NB338G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
||
|
WHO-ATC |
P03AX01
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
||
|
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION |
SCCS/1459/11
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
13.5
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
||
|
JECFA EVALUATION |
BENZYL BENZOATE
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
||
|
EPA PESTICIDE CODE |
9501
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
||
|
WHO-VATC |
QP53AX11
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB13023MIG
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
204-402-9
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
DTXSID8029153
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
m2400
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | Merck Index | ||
|
8081
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
120-51-4
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL1239
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
benzyl benzoate
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
309
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
2345
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
208
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
N863NB338G
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
C65255
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
1062008
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
100000091327
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
C006723
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
41237
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
BENZYL BENZOATE
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | Description: A clear, colourless, oily liquid; odour, faintly aromatic. Miscibility: Practically immiscible with water and glycerol R; miscible with ethanol (~750 g/l) TS and ether R. Category: Scabicide (topical use). Storage: Benzyl benzoate should be kept in a tightly closed and well-filled container, protected from light. Additional information: Benzyl benzoate may slowly decompose on contact with air. Definition: Benzyl benzoate contains not less than 98.0% and not more than 100.5% of C14H12O2. | ||
|
335
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
BENZYL BENZOATE
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
19044
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | RxNorm | ||
|
DB00676
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY | |||
|
N863NB338G
Created by
admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT MAY BE PRESENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> IMPURITY |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
http://apps.who.int/phint/pdf/b/Jb.6.1.51.pdf
|